GALE is a steal at these prices. It will pop as the shorts cover at these low prices. Compared to other similar stocks at this price range GALE has way way more going. A lowered price target from 9 bucks to 7 bucks didn't help but that was a few days ago while GALE was over 2.60, watch some new price targets come out and remember phase 3 for Neuvax is a potential grand slam. Even if that doesn't pan out they are still gaining market share with Cancer drugs.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.